Clinical TrialsSearch results
Number of results: 832
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- Assessment of the efficacy of the use of zoledronic acid in the prevention of aromatase inhibitor-associated bone loss in postmenopausal women with hormone receptor-positive breast cancer who received letrozole as adjuvant therapy
- Postmenopausal Breast Cancer
- Cancer Institute Hospital
- 2008-03-29
Other
- Assessment study on validity of the Intervention Therapies for coronary artery disease in Japan
- Coronary artery disease
- National Hospital Organization
- 2007-09-01
Other
- Atorva-af prevention study
- ischemic heart disease
- Showa University School of Medicine Thoracic and cardiovascular surgery
- 2009-10-01
Other
- Basket study of tucatinib and trastuzumab in solid tumors with HER2 alterations
- Cervical, Uterine, biliary tract, urothelial Cancers, NSCLC, Breast Cancer - Other solid tumors
- Ramos Jorge
- 2021-05-25
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Biweekly Paclitaxel+Carboplatin for elderly patients with untreated nonresectable non-small cell lung cancer
- Non-small cell lung cancer
- Keio University School of Medicine Division of Pulmonary Medicine
- 2008-08-23
Other
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Hypertension
- EBM Collaborating Research Center in Kyoto University
- 2005-10-30
Other
- Chemoselection as a strategy for organ preservation in clinical stage II/III ESCC: a phase II study of induction chemotherapy with docetaxel, cisplatin and 5-FU (DCF) followed by chemoradiotherapy.
- Problem(s) Studied
- Watanabe Akinori
- 2019-03-19
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09